Based on a new technology called QuantumPACK™, we will open a new
horizon for in vitro diagnostics, provide excellent performance diagnositc
products for both healthcare officials and patients, and greatly
contribute to the promotion of the human cavity.
BioSquare is proud to announce the launch of COVID-19 antigen and Influenza A+B lateral flow diagnostic kits based on QuantumPACK™ and NanoPACK™ technology.